Apricus Biosciences Inc (NASDAQ:APRI)

0.408
Delayed Data
As of Jun 22
 -0.0064 / -1.54%
Today’s Change
0.25
Today|||52-Week Range
3.34
-77.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-22.5M-19.0M-7.4M-11.7M
 
 
 
 
 
Depreciation170.0K300.0K289.0K117.0K
 
 
 
 
 
Total Other Cash Flow5.5M-1.6M-4.9M2.3M
 
 
 
 
 
Funds From Operations-16.8M-20.3M-12.0M-9.4M
 
 
 
 
 
Funds From/For Other Operating Expenses1.3M2.3M1.0M1.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-18.0M-22.6M-13.1M-10.6M
 
 
 
 
 
 
InvestingCapital Expenditures-580.0K-337.0K-18.0K0.00
 
 
 
 
Fixed Asset Disposal50.0K5.0K3.0K0.00
 
 
 
 
Other Investing - Sources691.0K0.000.0012.3M
 
 
 
Net Cash Flow Investing161.0K-332.0K-15.0K12.3M
 
 
 
 
 
 
FinancingShort Term Borrowings-2.8M0.000.00-7.1M
 
 
 
Long Term Borrowings4.7M5.0M0.000.00
 
 
 
Long Term Debt Reduction-27.0K-501.0K-3.1M0.00
 
 
 
 
Net Proceeds Stock Sale5.9M11.0M14.1M9.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing42.0K10.0K0.00289.0K
 
 
 
 
Other Uses - Financing42.0K--0.00--
 
 
Net Cash Flow - Financing7.9M15.5M11.0M2.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-10.0M-7.5M-2.1M4.2M